Semaglutide is a synthetic analogue of glucagon-like peptide-1 (GLP-1), a naturally occurring incretin hormone. Widely utilized in preclinical and clinical research for the investigation of GLP-1 receptor signaling, pancreatic beta-cell function, insulin secretion, and the central nervous system mechanisms governing appetite and energy balance.

Research applications include the study of type 2 diabetes pathophysiology, metabolic disorders, cardiovascular risk factors associated with metabolic syndrome, and hepatic lipid accumulation. Semaglutide has been extensively studied in research models for its prolonged half-life and sustained receptor engagement compared to native GLP-1.

Each vial contains 5mg of lyophilized Semaglutide peptide. Reconstitute with bacteriostatic water prior to use in research applications.

Disclaimer: This product is intended for in vitro research and laboratory use only. It is not intended for human or veterinary use, consumption, or injection. Not approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease or medical condition. For use by qualified researchers only.